Diseases, Conditions, Syndromes

COVID-19 weakly correlated with chilblains incidence

(HealthDay)—There is a weak correlation for COVID-19 cases with incidence of chilblains, according to a study published online June 23 in JAMA Dermatology.

Patrick E. McCleskey, M.D., from The Permanente Medical Group Northern California in Oakland, and colleagues conducted a retrospective cohort study to examine the potential correlation between COVID-19 incidence and chilblains. Data were included for 780 patients with chilblains reported during the pandemic.

The researchers observed a correlation for COVID-19 incidence with chilblains incidence at 207 location-months (Spearman coefficient, 0.18). Of the 456 patients with chilblains tested during the pandemic, only 3.7 percent were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and only 2.0 percent were positive for SARS-CoV-2 within six weeks of chilblains diagnosis. Test results from 1.0 percent of patients were positive for immunoglobulin G antibodies to SARS-CoV-2. COVID-19, but not chilblains, disproportionately affected Latinx patients.

“Although this study found a weak geographic and temporal correlation of COVID-19 cases with chilblains cases, these findings may have resulted from behavioral changes,” the authors write. “Very few cases of chilblains were positive for COVID-19.”


Chilblains in recent case series not tied to COVID-19 infection


More information:
Abstract/Full Text

Copyright © 2021 HealthDay. All rights reserved.

Citation:
COVID-19 weakly correlated with chilblains incidence (2021, June 24)
retrieved 24 June 2021
from https://medicalxpress.com/news/2021-06-covid-weakly-chilblains-incidence.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.